ArticleCancer drug resistance (Alhambra, Calif.)2022

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.

Stefania Morganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.